Browse studies

Find your next paid study

1,058 recruiting studies matching your filters

Postpartum Activity and Expression of BCRP and OCT1 Drug Transporters in the Mammary Gland

This is a prospective, non-randomized, phase I study design evaluating the in vivo activities and expression of OCT1 and BCRP in mammary gland of lactating wom…

PostpartumLactationDrugs in Breast Milk+3 more

Estimated

~$10 – $6,250

University of WashingtonNCT06056583

UCF MammoChat: An AI-Driven Platform for Personalized Breast Cancer Patient Support -Image Repository

This study aims to develop AI models to better read diagnostic mammograms for various populations and types of breast cancer, using the images that participant…

Breast CancerBreast Cancer AwarenessBreast Cancer Detection+3 more

Estimated

~$10 – $750

University of Central FloridaNCT07214883

Sample Collection for Ongoing Research and Product Evaluation (SCORE) Study

The SCORE study is a prospective, multi-site clinical trial designed to collect blood and tissue samples, along with relevant clinical data, from participants …

Breast CancerLung CancerMuscle Invasive Bladder Cancer+9 more

Estimated

~$10 – $1,050

Natera, Inc.NCT07318051

Phase 2

Genetically-informed Therapy for ER+ Breast Cancer in a Post-CDK4/6 Inhibitor Setting: a Phase II Umbrella Study (GERTRUDE)

The purpose of this study is to learn if certain drug combinations are effective treatments for patients with advanced ER+/HER2- who have previously been treat…

Advanced Breast Cancer

Estimated

~$10 – $6,250

Dartmouth-Hitchcock Medical CenterNCT05933395

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia (AML) Using Remote Symptom Monitoring

The goal of this study is to create a data set to add to Carevive's registry from real world clinical and patient reported data collected using an electronic c…

Breast CancerLung CancerMultiple Myeloma+2 more

Estimated

~$10 – $1,050

Carevive Systems, Inc.NCT05974150

Observational

Addressing Disparities in Breast Cancer Care: An Approach to Health Equity

This clinical trial evaluates a patient navigation program for addressing disparities in breast cancer care. The navigation program is designed to help improve…

Breast CarcinomaBreast Ductal Carcinoma in Situ

Estimated

~$10 – $7,500

Roswell Park Cancer InstituteNCT06350500

Exploratory Next Generation Sequencing to Identify Causative Variants for Taxane-Induced Peripheral Neuropathy From Breast Cancer Study E5103 Germline DNA Samples

This research trial studies whole exome sequencing in finding causative variants in germline deoxyribonucleic acid (DNA) samples from patients with peripheral …

Breast CarcinomaNeuropathy

Estimated

~$10 – $675

National Cancer Institute (NCI)NCT02610439

Phase 1

A Phase 1 Dose-Escalation and Expansion Study of Intratumorally Administered ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas

A phase 1, multicenter, open label, non-randomized dose escalation and dose expansion study to examine the maximum tolerated dose, (MTD), minimum effective dos…

Triple Negative Breast CancerDiffuse Large B Cell LymphomaFollicular Lymphoma+11 more

Estimated

~$10 – $8,750

OncoNano Medicine, Inc.NCT06022029

Phase 1

Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy: A First in Human Randomized Pilot Study. Neuromodulation in Cancer Study (OU-SCC-NCAN)

This study is to determine if low level vagus nerve stimulation will lead to improvement in heart function, heart rate variation, and in the levels of certain …

Breast CancerLymphoma

Estimated

~$10 – $6,250

University of OklahomaNCT05921253

Observational

Evaluation of the Bexa Breast Examination (BBE) as an Effective Solution to Breast Cancer Early Detection

Objective: The "Bexa Breast Exam," or "BBE," for the purposes of this study is defined as the use of a Bexa device in conjunction with a portable, focused ult…

Breast Cancer

Estimated

~$10 – $8,750

Sure, Inc.NCT06643767

Phase 3

A Global, Multicenter, Three Arms, Open-label Randomized Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension Compared to Taxotere® (Docetaxel Injection Concentrate) in Triple-negative Breast Cancer Patients With Locally Advanced or Metastatic Breast Cancer After Failure to Prior Chemotherapy

The Nanosomal Docetaxel Lipid Suspension (NDLS) consists of uniformly sized micro particles of docetaxel suspended in a lipid based formulation. The advantage …

Triple Negative Breast Cancer

Estimated

~$10 – $8,750

Jina Pharmaceuticals Inc.NCT03671044

Phase 2

Individualizing Approaches to Surveillance Mammography in Older Breast Cancer Survivors - The I-MAMMO Study

This study evaluates the effectiveness of a Shared Decision-Making (SDM) toolkit designed to support older breast cancer survivors aged 80 and above in making …

Breast Cancer

Estimated

~$10 – $7,500

Dana-Farber Cancer InstituteNCT07123649